Translate the page
Feel free to ask any questions, leave your comments, wishes and suggestions regarding the Google Translation at our Telegram Chat.
Like this video

Vivo Capital

Future of Healthcare Innovation

Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1.7 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and revenue stage companies in China. Vivo Capital has offices in Palo Alto, California, Shanghai, and Beijing, China. At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees as well as for our investors. Vivo invests primarily in later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo assists its portfolio companies in both countries in forging cross-border partnerships, enabling the companies to acquire new products and expand the market for their existing products. In addition to making investments in existing companies, Vivo also builds companies from scratch to pursue compelling opportunities together with experienced management teams. Finally, a portion of every Vivo fund is invested directly into public therapeutics companies. Despite its focus on companies with later-stage products, Vivo is willing to work with companies (and their founders) that may not have significant infrastructure. We invest in companies with promising products at all financing stages (Series A to public companies), and work closely with founders and management to complete the development and commercial launch of those products and achieve a successful exit.

3.6
2 1 expert rating
Benchy 3.8
Experts
3.0
3.0
3.0
View rating distribution
Ended
2018-10-01 - 2018-10-15
46 days 23 hours left
2018-10-16 - 2018-12-31
Token
VCT
Price
1 VCT = 0.00002 ETH
Bounty
MVP/Prototype
Platform
Accepting
ETH
Minimum investment
0.1 ETH
Soft cap
120000000 USD
Hard cap
280000000 USD
Country
USA
Whitelist/KYC
KYC & Whitelist
More on ICO
Report

About Vivo Capital

Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1.7 billion under management, Vivo employs a unique multi-pronged strategy of identifying and working with companies with promising development stage and commercial stage therapeutic products in the U.S. and revenue stage companies in China. Vivo Capital has offices in Palo Alto, California, Shanghai, and Beijing, China.

At Vivo Capital, we leverage our internal expertise in evaluating data to generate outsized returns for company founders and employees as well as for our investors. Vivo invests primarily in later development stage pharmaceutical and medical device companies in the U.S. and in revenue stage healthcare companies in greater China. Vivo assists its portfolio companies in both countries in forging cross-border partnerships, enabling the companies to acquire new products and expand the market for their existing products. In addition to making investments in existing companies, Vivo also builds companies from scratch to pursue compelling opportunities together with experienced management teams. Finally, a portion of every Vivo fund is invested directly into public therapeutics companies. Despite its focus on companies with later-stage products, Vivo is willing to work with companies (and their founders) that may not have significant infrastructure. We invest in companies with promising products at all financing stages (Series A to public companies), and work closely with founders and management to complete the development and commercial launch of those products and achieve a successful exit.

Bookmark
ICO KYC Report
Not conducted yet
KYC procedure verifies selected/specific team members only. It does not guarantee ICO success nor is a call for investment.
Missing or incorrect data? Let us know.

ICOs that might interest you

4.0

Talentico

Global decentralized ecosystem based on blockchain, where talented cryptoinvestors earn...

Starts in 33 days 23 hours
3.9

TheFund.io

TheFund.io is an investment Fund created to open access to earnings on investments.

164 days 23 hours left
3.7

Ternion

Bridging the gap between traditional and decentralized finances.

45 days 23 hours left
4.9

Whisky Token

WHISKY TOKEN (WHY) stands for a disruptive new possibility in the crypto currency marke...

15 days 23 hours left
Join our Official ICObench group on TelegramOfficial ICObench Telegram group

Cookies help us deliver our services. By using our services, you agree to our use of cookies.

Learn more Got it